Contact
Please use this form to send email to PR contact of this press release:
FDA approves taletrectinib for ROS1-positive non-small cell lung cancer
TO:
Please use this form to send email to PR contact of this press release:
FDA approves taletrectinib for ROS1-positive non-small cell lung cancer
TO: